| Literature DB >> 28254463 |
Paolo Gionchetti1, Fernando Rizzello2, Vito Annese3, Alessandro Armuzzi4, Livia Biancone5, Fabiana Castiglione6, Michele Comberlato7, Mario Cottone8, Silvio Danese9, Marco Daperno10, Renata D'Incà11, Walter Fries12, Anna Kohn13, Ambrogio Orlando8, Claudio Papi14, Maurizio Vecchi15, Sandro Ardizzone16.
Abstract
The two main forms of intestinal bowel disease, namely ulcerative colitis and Crohn's disease, are not curable but can be controlled by various medical therapies. The Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) has prepared clinical practice guidelines to help physicians prescribe corticosteroids and immunosuppressive drugs for these patients. The guidelines consider therapies that induce remission in patients with active disease as well as treatment regimens that maintain remission. These guidelines complement already existing guidelines from IG-IBD on the use of biological drugs in patients with inflammatory bowel diseases.Entities:
Keywords: Corticosteroids; Crohn's disease; Guidelines; IBD; Immunosuppressors; Ulcerative colitis
Mesh:
Substances:
Year: 2017 PMID: 28254463 DOI: 10.1016/j.dld.2017.01.161
Source DB: PubMed Journal: Dig Liver Dis ISSN: 1590-8658 Impact factor: 4.088